228 related articles for article (PubMed ID: 24778235)
1. Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation.
Rivlin N; Katz S; Doody M; Sheffer M; Horesh S; Molchadsky A; Koifman G; Shetzer Y; Goldfinger N; Rotter V; Geiger T
Proc Natl Acad Sci U S A; 2014 May; 111(19):7006-11. PubMed ID: 24778235
[TBL] [Abstract][Full Text] [Related]
2. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
Lang GA; Iwakuma T; Suh YA; Liu G; Rao VA; Parant JM; Valentin-Vega YA; Terzian T; Caldwell LC; Strong LC; El-Naggar AK; Lozano G
Cell; 2004 Dec; 119(6):861-72. PubMed ID: 15607981
[TBL] [Abstract][Full Text] [Related]
3. Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis.
Hanel W; Marchenko N; Xu S; Yu SX; Weng W; Moll U
Cell Death Differ; 2013 Jul; 20(7):898-909. PubMed ID: 23538418
[TBL] [Abstract][Full Text] [Related]
4. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.
Xian W; Miron A; Roh M; Semmel DR; Yassin Y; Garber J; Oliva E; Goodman A; Mehra K; Berkowitz RS; Crum CP; Quade BJ
J Pathol; 2010 Jan; 220(1):17-23. PubMed ID: 19834951
[TBL] [Abstract][Full Text] [Related]
5. The amplifier effect: how Pin1 empowers mutant p53.
Hu H; Wulf GM
Breast Cancer Res; 2011 Oct; 13(5):315. PubMed ID: 22017796
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of p53 suppresses Nanog expression in embryonic stem cells.
Abdelalim EM; Tooyama I
Biochem Biophys Res Commun; 2014 Jan; 443(2):652-7. PubMed ID: 24333425
[TBL] [Abstract][Full Text] [Related]
7. CKIα ablation highlights a critical role for p53 in invasiveness control.
Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
[TBL] [Abstract][Full Text] [Related]
8. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
[TBL] [Abstract][Full Text] [Related]
9. p53 and disease: when the guardian angel fails.
Royds JA; Iacopetta B
Cell Death Differ; 2006 Jun; 13(6):1017-26. PubMed ID: 16557268
[TBL] [Abstract][Full Text] [Related]
10. A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.
Koifman G; Shetzer Y; Eizenberger S; Solomon H; Rotkopf R; Molchadsky A; Lonetto G; Goldfinger N; Rotter V
Cancer Res; 2018 Oct; 78(20):5833-5847. PubMed ID: 30154152
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.
Chae HD; Lee MR; Broxmeyer HE
Stem Cells; 2012 Feb; 30(2):140-9. PubMed ID: 22076938
[TBL] [Abstract][Full Text] [Related]
12. Nucleolin maintains embryonic stem cell self-renewal by suppression of p53 protein-dependent pathway.
Yang A; Shi G; Zhou C; Lu R; Li H; Sun L; Jin Y
J Biol Chem; 2011 Dec; 286(50):43370-82. PubMed ID: 22013067
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
14. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation.
Huskey NE; Guo T; Evason KJ; Momcilovic O; Pardo D; Creasman KJ; Judson RL; Blelloch R; Oakes SA; Hebrok M; Goga A
Stem Cell Reports; 2015 Mar; 4(3):374-89. PubMed ID: 25733019
[TBL] [Abstract][Full Text] [Related]
15. Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage.
Solozobova V; Rolletschek A; Blattner C
BMC Cell Biol; 2009 Jun; 10():46. PubMed ID: 19534768
[TBL] [Abstract][Full Text] [Related]
16. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
Lu X; Liu DP; Xu Y
Oncogene; 2013 Jun; 32(23):2900-6. PubMed ID: 22824795
[TBL] [Abstract][Full Text] [Related]
17. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
[TBL] [Abstract][Full Text] [Related]
18. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.
Ungewitter E; Scrable H
Genes Dev; 2010 Nov; 24(21):2408-19. PubMed ID: 21041409
[TBL] [Abstract][Full Text] [Related]
19. Rewired m
Xu A; Liu M; Huang MF; Zhang Y; Hu R; Gingold JA; Liu Y; Zhu D; Chien CS; Wang WC; Liao Z; Yuan F; Hsu CW; Tu J; Yu Y; Rosen T; Xiong F; Jia P; Yang YP; Bazer DA; Chen YW; Li W; Huff CD; Zhu JJ; Aguilo F; Chiou SH; Boles NC; Lai CC; Hung MC; Zhao Z; Van Nostrand EL; Zhao R; Lee DF
Nat Commun; 2023 Mar; 14(1):1694. PubMed ID: 36973285
[TBL] [Abstract][Full Text] [Related]
20. Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.
Dibra D; Mitra A; Newman M; Xia X; Cutrera JJ; Gagea M; Kleinerman ES; Lozano G; Li S
Clin Cancer Res; 2016 Aug; 22(15):3876-83. PubMed ID: 26979394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
